Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

alpha1-AT QOtrastevere

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
BACKGROUND & AIMS In most genetic diseases, the goal of gene therapy is to deliver a particular transgene; however, sometimes a… Expand
Highly Cited
2001
Highly Cited
2001
alpha1-Antitrypsin (alpha1-AT) is the most abundant circulating proteinase inhibitor. The Z variant results in profound plasma… Expand
1997
1997
OBJECTIVES To ascertain how long 120 mg/kg alpha1-antitrypsin concentrate (alpha1-AT-C), administered I.V. every 2 weeks, can… Expand
Highly Cited
1996
Highly Cited
1996
We have theorized that a subset of PiZZ α1-antitrypsin (α1-AT)-deficient individuals is more susceptible to liver injury by… Expand